Trump's pharmaceutical tariffs could affect some drugmakers more than others
1. Trump plans to impose tariffs on imported pharmaceuticals starting Aug. 1. 2. Companies like AbbVie and Eli Lilly are well-positioned against tariffs. 3. Higher tariffs could significantly impact drugmakers' cash flow and R&D spending. 4. Drug prices may rise, worsening affordability issues for patients. 5. Manufacturing shifts to the U.S. are anticipated to mitigate tariff impacts.